newsfilter
← Latest News
FDA Approved Drugs·

Approval of Ojjaara, Nda #216873 (Labeling)

Approval Date: 07/20/2026; Drug Name: Ojjaara, Nda #216873; Active Ingredients: MOMELOTINIB DIHYDROCHLORIDE; Company: Glaxosmithkline; Submission Status: Approval; Submission Classification: Labeling; Application Number: 216873

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE